Skip to main content
Erschienen in: Trials 1/2020

Open Access 09.06.2020 | COVID-19 | Letter

The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial

verfasst von: Carlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, Gemma Moncunill, Aina Casellas, Francisco Carmona-Torre, Miriam Giráldez, Juana Schwartz Mota, José Ramón Yuste, José Ramón Azanza, Miriam Fernández, Gabriel Reina, Carlota Dobaño, Joe Brew, Belen Sadaba, Felix Hammann, Regina Rabinovich

Erschienen in: Trials | Ausgabe 1/2020

download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
verfasst von
Carlos Chaccour
Paula Ruiz-Castillo
Mary-Ann Richardson
Gemma Moncunill
Aina Casellas
Francisco Carmona-Torre
Miriam Giráldez
Juana Schwartz Mota
José Ramón Yuste
José Ramón Azanza
Miriam Fernández
Gabriel Reina
Carlota Dobaño
Joe Brew
Belen Sadaba
Felix Hammann
Regina Rabinovich
Publikationsdatum
09.06.2020
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04421-z

Weitere Artikel der Ausgabe 1/2020

Trials 1/2020 Zur Ausgabe